Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)

A. Touil (Tunis, Tunisia), F. Yangui (Tunis, Tunisia), S. Antit (Tunis, Tunisia), L. Zakhama (Tunis, Tunisia), S. Ben Youssef (Tunis, Tunisia), M. Charfi (Tunis, Tunisia)

Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session: Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session type: Poster Discussion
Number: 5014
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Touil (Tunis, Tunisia), F. Yangui (Tunis, Tunisia), S. Antit (Tunis, Tunisia), L. Zakhama (Tunis, Tunisia), S. Ben Youssef (Tunis, Tunisia), M. Charfi (Tunis, Tunisia). Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD). 5014

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006

The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007

Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020




The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Predictors of arrhythmias in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT)
Source: Eur Respir J 2007; 30: Suppl. 51, 122s
Year: 2007

Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007


Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005

Correlates of osteoporosis in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Chronic obstructive pulmonary disease (COPD) and myocardial ischemia (MI) comorbidity
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


Awareness of chronic obstructive pulmonary disease (COPD) in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007

Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Increased arterial stiffness in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 65s
Year: 2006

Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008

Clinical factors linked with coronary artery disease in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002